Some improvements in diabetes care happen slowly, whereas others seem to happen very fast. For a number of reasons, in the last two years we have suddenly seen a dramatic change in our approach to insulin therapy. This has partly been due to the roll-out of continuous and flash glucose monitoring. This, combined with the enforced inability to see people face to face, meant we had to develop tools for remote monitoring and has resulted in a dramatic increase in data sharing between people with diabetes and clinicians, particularly with regard to glucose levels throughout the day. Instead of a meeting where a paper glucose diary with perhaps two to four readings per day is reviewed, we now have a wealth of detail about day-to-day glucose variation.
This change has shifted the conversation in clinic and, as we know, resulted in measurable improvements for the individual with diabetes. It does, however, highlight a gaping hole in the information that we need in order to give accurate advice: we know very little about the appropriateness and timing of insulin doses. At the moment, the information we have for an individual using insulin pump therapy will be very different to the information available for a person using multiple daily injections of insulin. Often we can only assume that insulin has, firstly, been taken and, secondly, been taken at an appropriate time and dose for that meal. Evidence would suggest that this assumption will be incorrect for a relatively high proportion of the time.
This paper by Susan Robinson and colleagues summarises our current knowledge about the timing of insulin injections for people with both type 1 and type 2 diabetes. The results are sobering but perhaps not surprising, with one or two doses of insulin being missed per person per week. The timing of bolus insulin in relation to meals is also important and, while we often assume in the clinic that the dose is being taken at the right point, the data would suggest this is probably not the case around 50% of the time.
These are the basics of insulin self-administration that we mostly assume are understood and practised correctly before considering factors such as matching the insulin dose to the carbohydrate content of the meal, the proportion of the previous insulin injection still active, correction doses to manage the current glucose level and the effects of previous or planned physical activity. When there is a problem with glucose control, we often assume it is these complexities that need addressing, without considering that just remembering to take the insulin correctly may be a challenge.
Technology is already helping, with automated systems to help calculate insulin doses and smart pens to remind about insulin injections, but in addition the consultation needs to evolve to deal with this new conversation. To best help the person with diabetes, we need to match the wealth of glucose data with equally accurate measures of insulin dose and timing. Hopefully this will come in the near future.
Click here to read the Digest.
Diabetes Digest
Issue:
Early View
The challenge of multiple daily insulin injections
Some improvements in diabetes care happen slowly, whereas others seem to happen very fast. For a number of reasons, in the last two years we have suddenly seen a dramatic change in our approach to insulin therapy. This has partly been due to the roll-out of continuous and flash glucose monitoring. This, combined with the enforced inability to see people face to face, meant we had to develop tools for remote monitoring and has resulted in a dramatic increase in data sharing between people with diabetes and clinicians, particularly with regard to glucose levels throughout the day. Instead of a meeting where a paper glucose diary with perhaps two to four readings per day is reviewed, we now have a wealth of detail about day-to-day glucose variation.
This change has shifted the conversation in clinic and, as we know, resulted in measurable improvements for the individual with diabetes. It does, however, highlight a gaping hole in the information that we need in order to give accurate advice: we know very little about the appropriateness and timing of insulin doses. At the moment, the information we have for an individual using insulin pump therapy will be very different to the information available for a person using multiple daily injections of insulin. Often we can only assume that insulin has, firstly, been taken and, secondly, been taken at an appropriate time and dose for that meal. Evidence would suggest that this assumption will be incorrect for a relatively high proportion of the time.
This paper by Susan Robinson and colleagues summarises our current knowledge about the timing of insulin injections for people with both type 1 and type 2 diabetes. The results are sobering but perhaps not surprising, with one or two doses of insulin being missed per person per week. The timing of bolus insulin in relation to meals is also important and, while we often assume in the clinic that the dose is being taken at the right point, the data would suggest this is probably not the case around 50% of the time.
These are the basics of insulin self-administration that we mostly assume are understood and practised correctly before considering factors such as matching the insulin dose to the carbohydrate content of the meal, the proportion of the previous insulin injection still active, correction doses to manage the current glucose level and the effects of previous or planned physical activity. When there is a problem with glucose control, we often assume it is these complexities that need addressing, without considering that just remembering to take the insulin correctly may be a challenge.
Technology is already helping, with automated systems to help calculate insulin doses and smart pens to remind about insulin injections, but in addition the consultation needs to evolve to deal with this new conversation. To best help the person with diabetes, we need to match the wealth of glucose data with equally accurate measures of insulin dose and timing. Hopefully this will come in the near future.
Click here to read the Digest.
Back to basics: An update on lifestyle factors, preventing gestational diabetes and sulfonylureas
Self-reported walking pace is a risk factor for type 2 diabetes
The Life’s Essential 8 cardiovascular health score and risk of premature death in people with and without type 2 diabetes
Gestational diabetes: Cost-effectiveness of offering routine lifestyle intervention in early pregnancy
Cardiovascular safety of sulfonylureas: Real-world observational study
You are what – and when – you eat
Low-carbohydrate diet scores reduce mortality in adults with incident type 2 diabetes
Vinod Patel highlights the growing evidence base that lifestyle interventions are effective, and encourages persistence even though they can be difficult.
25 May 2023
Both excess weight and slow walking pace are independent risk factors for type 2 diabetes.
25 May 2023
People with type 2 diabetes who maintain a high health score may reduce risk of premature death by as much as 58%.
25 May 2023
Routine implementation of a structured lifestyle intervention during pregnancy would be highly cost-effective from healthcare and societal perspectives.
25 May 2023